对治疗精神分裂症的新抗精神病药物进行临床导向的审查
Maria Luca1, Antonina Luca2, Alessandro Serretti2,3
1Centre for Addiction, Adrano-Bronte, Adrano (CT), Italy.
Neuropsychiatric disease and treatment
|January 1, 2025
概括
新的非多巴胺抗精神病药物对精神分裂症治疗有希望,但谨慎的乐观是有道理的. 虽然一些药物如xanomeline-trospium获得批准,但其他药物面临开发挑战,这凸显了需要仔细评估新的抗精神病药物选择的必要性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 目前的抗精神病药主要向多巴胺基通路,不足以解决精神分裂症的复杂性并引起不良事件.
- 创新的药理疗法至关重要,推动对非多巴胺类抗精神病药物的研究.
- 本综述侧重于有前途的非多巴胺类药物:肌肉氨基激活剂,微氨基关联受体1 (TAAR1) 激活剂,甘氨酸输送物1型 (GlyT-1) 抑制剂和5-HT2A对抗剂.
研究的目的:
- 审查有关新型非多巴胺类抗精神病药物的当前文献.
- 为这些药物在精神分裂症管理中的疗效,安全性和潜在应用提供临床概述.
- 为了确定每个药理类的晚期临床开发候选人.
主要方法:
- 已确定晚期临床候选药物:比托珀丁 (GlyT-1 抑制剂),皮马万塞林 (5-HT2A 抗剂),乌洛托朗特 (TAAR1 激动剂) 和克萨诺梅林-托斯皮 (肌酸激动剂).
- 在PubMed上进行文献搜索,寻找这些选择药物的疗效和安全性数据.
- 利用临床试验数据库进行初步药物选择.
主要成果:
- 尽管最初有承诺,但比托珀丁和皮马万塞林的临床开发已被停止.
- 赞诺梅林-托斯皮化物获得了FDA批准用于治疗精神分裂症.
- 乌洛塔伦特显示混合结果,正在进行分析.
结论:
- 精神分裂症治疗研究正在推进,但由于过去的失败,建议谨慎.
- 在评估新的和已批准的抗精神病药物时,需要采取平衡的方法,考虑其成本效益比率.
- 目前正在进行的试验为未来精神分裂症治疗的治疗进展提供了希望.
更多相关视频
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
14.5K
12:00Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
Published on: November 19, 2014
12.8K
相关概念视频
01:28Psychosis and Antipsychotic Drugs: Overview
151
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
151
01:26Psychosis: Goals of Pharmacotherapy
95
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
95
01:21Antipsychotic Drugs: Typical and Atypical Agents
120
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
120
01:28Drug Therapy
23
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
23
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
98
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
98
01:23Antidepressant Drugs: MAOIs and Other Agents
157
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
157